Literature DB >> 8564947

Histone H3 messenger RNA in situ hybridization correlates with in vivo bromodeoxyuridine labeling of S-phase cells in rat colonic epithelium.

H Konishi1, G Steinbach, N H Terry, J J Lee, J A Dubin, G A Glober, K Fujita, D Spaulding, L Cass, W N Hittelman.   

Abstract

Measurements of cell cycle phase fractions, particularly S-phase, are useful for studies of cell biology and carcinogenesis. Up-regulation of histone gene expression is tightly coupled to the G1-S-phase transition of the cell cycle, and mRNA levels rise 30-100-fold during S-phase. Labeling of histone H3 mRNA using in situ hybridization (ISH) was assessed as a measure of S-phase cells and compared with that found using in vivo 5-bromodeoxyuridine (BrdUrd) labeling in formalin-fixed rat colonic crypts under baseline, modified 72-h starvation, and 24-h refeeding conditions. The labeling index scored in single-labeled sections by histone H3 ISH tightly correlated with that found by in vivo BrdUrd labeling (r = 0.99, p < 0.0001) and clearly discriminated between the control, starved, and refed states (P < 0.001). In 180 crypt sections double labeled using histone H3 ISH and BrdUrd, 92% of 1572 labeled cells exhibited both nuclear BrdUrd and cytoplasmic histone H3 label. It is concluded that histone H3 ISH is an accurate measure of the S-phase fraction and provides an alternative to in vivo BrdUrd labeling in rat colon. This finding warrants validation in human studies.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8564947

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  4 in total

1.  Histone H3 mRNA in situ hybridization for identifying proliferating cells in human pancreas, with special reference to the ductal system.

Authors:  N Arakura; M Hayama; T Honda; K Matsuzawa; T Akamatsu; H Ota
Journal:  Histochem J       Date:  2001-03

2.  E4F1, a novel estrogen-responsive gene in possible atheroprotection, revealed by microarray analysis.

Authors:  Yasuhiro Nakamura; Katsuhide Igarashi; Takashi Suzuki; Jun Kanno; Tohru Inoue; Chika Tazawa; Masayuki Saruta; Tomoko Ando; Noriko Moriyama; Toru Furukawa; Masao Ono; Takuya Moriya; Kiyoshi Ito; Haruo Saito; Tadashi Ishibashi; Shoki Takahashi; Shogo Yamada; Hironobu Sasano
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

3.  Normal remodeling of the oxygen-injured lung requires the cyclin-dependent kinase inhibitor p21(Cip1/WAF1/Sdi1).

Authors:  Rhonda J Staversky; Richard H Watkins; Terry W Wright; Eric Hernady; Michael B LoMonaco; Carl T D'Angio; Jacqueline P Williams; William M Maniscalco; Michael A O'Reilly
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

4.  A novel gene signature for molecular diagnosis of human prostate cancer by RT-qPCR.

Authors:  Federica Rizzi; Lucia Belloni; Pellegrino Crafa; Mirca Lazzaretti; Daniel Remondini; Stefania Ferretti; Piero Cortellini; Arnaldo Corti; Saverio Bettuzzi
Journal:  PLoS One       Date:  2008-10-31       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.